Twin Tree Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-5,626
| Closed | -$312K | – | 1627 |
|
|
2025
Q3 | $312K | Sell |
5,626
-239,522
| -98% | -$14M | ﹤0.01% | 1317 |
|
|
2025
Q2 | $16.9M | Sell |
245,148
-44,050
| -15% | -$3M | 0.03% | 551 |
|
|
2025
Q1 | $20.1M | Buy |
+289,198
| New | +$23.9M | 0.04% | 433 |
|
|
2024
Q4 | – | Sell |
-204,957
| Closed | -$22.2M | – | 1822 |
|
|
2024
Q3 | $24.4M | Buy |
204,957
+25,899
| +14% | +$3.45M | 0.05% | 351 |
|
|
2024
Q2 | $25.6M | Buy |
179,058
+56,725
| +46% | +$7.52M | 0.06% | 304 |
|
|
2024
Q1 | $15.7M | Buy |
+122,333
| New | +$14.6M | 0.03% | 481 |
|
|
2023
Q4 | – | Sell |
-87,246
| Closed | -$8.63M | – | 1529 |
|
|
2023
Q3 | $7.93M | Sell |
87,246
-130,224
| -60% | -$11.5M | 0.02% | 571 |
|
|
2023
Q2 | $17.6M | Buy |
+217,470
| New | +$17.8M | 0.03% | 459 |
|
|
2022
Q3 | – | Sell |
-155,724
| Closed | -$8.34M | – | 1580 |
|
|
2022
Q2 | $8.68M | Buy |
+155,724
| New | +$8.64M | 0.01% | 685 |
|
|
2022
Q1 | – | Sell |
-300,416
| Closed | -$15.4M | – | 1812 |
|
|
2021
Q4 | $16.8M | Buy |
300,416
+231,916
| +339% | +$12.6M | 0.04% | 457 |
|
|
2021
Q3 | $3.29M | Buy |
68,500
+58,066
| +557% | +$2.81M | 0.01% | 909 |
|
|
2021
Q2 | $437K | Buy |
10,434
+7,078
| +211% | +$274K | ﹤0.01% | 1129 |
|
|
2021
Q1 | $113K | Sell |
3,356
-5,964
| -64% | -$212K | ﹤0.01% | 1170 |
|
|
2020
Q4 | $326K | Buy |
+9,320
| New | +$322K | ﹤0.01% | 1072 |
|
|
2019
Q3 | – | Sell |
-151,016
| Closed | -$3.85M | – | 1421 |
|
|
2019
Q2 | $3.85M | Buy |
151,016
+146,428
| +3,192% | +$3.62M | 0.02% | 522 |
|
|
2019
Q1 | $120K | Sell |
4,588
-58,326
| -93% | -$1.43M | ﹤0.01% | 1075 |
|
|
2018
Q4 | $1.45M | Buy |
62,914
+47,282
| +302% | +$1.05M | 0.01% | 793 |
|
|
2018
Q3 | $368K | Buy |
+15,632
| New | +$381K | ﹤0.01% | 878 |
|
|
2018
Q2 | – | Sell |
-15,214
| Closed | -$375K | – | 1292 |
|
|
2018
Q1 | $375K | Sell |
15,214
-15,360
| -50% | -$403K | ﹤0.01% | 840 |
|
|
2017
Q4 | $820K | Sell |
30,574
-6,580
| -18% | -$167K | 0.01% | 745 |
|
|
2017
Q3 | $894K | Buy |
+37,154
| New | +$840K | 0.01% | 695 |
|
|
2017
Q2 | – | Sell |
-10,922
| Closed | -$220K | – | 1114 |
|
|
2017
Q1 | $187K | Buy |
10,922
+1,214
| +13% | +$21.1K | ﹤0.01% | 843 |
|
|
2016
Q4 | $174K | Sell |
9,708
-7,494
| -44% | -$136K | ﹤0.01% | 991 |
|
|
2016
Q3 | $358K | Buy |
+17,202
| New | +$427K | ﹤0.01% | 879 |
|
|
2016
Q2 | – | Sell |
-85,688
| Closed | -$2.32M | – | 1348 |
|
|
2016
Q1 | $2.32M | Buy |
85,688
+76,172
| +800% | +$2.04M | 0.04% | 383 |
|
|
2015
Q4 | $276K | Buy |
+9,516
| New | +$263K | 0.01% | 1020 |
|
|
2015
Q3 | – | Sell |
-5,850
| Closed | -$166K | – | 1466 |
|
|
2015
Q2 | $160K | Sell |
5,850
-152,568
| -96% | -$4.29M | ﹤0.01% | 1101 |
|
|
2015
Q1 | $4.23M | Buy |
+158,418
| New | +$3.65M | 0.11% | 210 |
|
|
2014
Q2 | – | Sell |
-6,360
| Closed | -$145K | – | 991 |
|
|
2014
Q1 | $145K | Sell |
6,360
-1,660
| -21% | -$35.4K | ﹤0.01% | 847 |
|
|
2013
Q4 | $148K | Sell |
8,020
-9,580
| -54% | -$167K | ﹤0.01% | 856 |
|
|
2013
Q3 | $298K | Sell |
17,600
-27,390
| -61% | -$461K | 0.01% | 678 |
|
|
2013
Q2 | $697K | Buy |
+44,990
| New | +$749K | 0.03% | 536 |
|
Other funds holding NVO
F
Twin Tree Management's NVO Position: Q4 2025 in Review
Twin Tree Management sold out of Novo Nordisk (NVO) in Q4 2025, closing a stake of 5,626 shares — an estimated $312K sold.
Twin Tree Management first reported a position in NVO in Q2 2013 and held it in 32 quarters. The position peaked at $25.6M in Q2 2024. 1,418 funds tracked by Wall St. Rank hold NVO as of Q4 2025.
- Twin Tree Management reported no remaining Novo Nordisk position as of Q4 2025 after selling out during the quarter.
- Twin Tree Management sold 5,626 Novo Nordisk shares in Q4 2025, an estimated $312K.
- Twin Tree Management first reported a position in Novo Nordisk in Q2 2013 and held it in 32 quarters.
- Twin Tree Management's Novo Nordisk position peaked at $25.6M in Q2 2024.
- 1,418 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2025.
Based on Twin Tree Management's 13F filing for Q4 2025, filed 11 Feb 2026.